1.Changes in the sagittal plane spinal alignment at the time of the cross-leg sitting position
Yukio Urabe ; Hiroshi Shinohara ; Takuya Takeuchi ; Shogo Tsutsumi
Japanese Journal of Physical Fitness and Sports Medicine 2017;66(5):363-367
Cross-leg sitting is locus posture performed well in Asian area, and a lifestyle and culture are thought to affect it. It is usually essential to cross-leg sitting carried out in the case of Zen meditation to maintain cross-leg sitting locus in a relaxed state to perform locus posture in floor, and to perform it in hip joint flexion of bilateral feet, abduction, and lateral rotation position in the meditation for a long time. The spinal column of cross-leg sitting was intended that aligning it confirmed backbone in lumbar vertebrae being displaced than rest standing position in the kyphosis direction or raising a bearing surface whether aligning it changed into lordotic projection from the lumbar vertebrae kyphosis direction. The thoracic vertebra angle and the lumbar vertebrae angle measured it using SpinalMouse®. We decided to measure a thoracic vertebra angle, a lumbar vertebrae angle when we changed the height of the target rest standing position and the bearing surface of cross-leg sitting. The thoracic vertebra angle did not change by raising the bearing surface of cross-leg sitting, however the lumbar vertebrae angle changed. It showed a significant correlation between hip joint flexion, abduction, an external rotation angles and the change of the lumbar vertebrae angle. Results of this study suggested that lumbar, aligning it changed to lordosis in the high cross-leg sitting thing that we changed. The quantity that aligning it biases into lordosis of the lumbar part is related to the flexion of the hip joint, abduction, external rotation flexibility.
2.Epidemiological studies on Clonorchis sinensis infection along the Nam-river in Gyeongnam province, Korea.
Kyoung Hoon BAE ; Yung Kyum AHN ; Chin Thack SOH ; Hiroshi TSUTSUMI
The Korean Journal of Parasitology 1983;21(2):167-186
The prevalence of C. sinensis infection along the Nam river, Korea, was 38.7% of 5,291 people examined. Prevalence rates varied from 42% at the upper stream to 34% at the middle stream and 40% at the down stream region. Rates were highest (53.4-54.3%) in the 30-59 years of age group. The positive rates in primary school chidren, school students, teachers and local officers, and other inhabitants were 16.5%, 22.6%, 46.2% and 49.6% respectively. 53.6% of cases were light infected, i.e. less than 4,000/EPG. The cercarial expulsion rate of 5,005 Parafossarulus sp. was 0.34%. Snails naturally infected with C. sinensis expelled about 788 cercariae/day. Ten of 18 species of freshwater fish examined had C. sinensis metacercariae. To prevent clonorchiasis in the endemic areas, the effective health education system is suggested as a control measure. [retyped from English summary]
parasitology-helminth-trmatoda
;
Clonorchis sinensis
;
clonorchiasis
;
epidemiology
;
Pseudorasbora parva
;
Parafossarulus sp.
;
Loxogenes liberum
;
Cyathocotyle orientalis
;
Notocotylus attenuatus
;
Zacco platypus
;
Hemibarbus sp.
;
Gnathopogon sp.
;
Ischikauia steenackeri
;
Pseudogobio esocinus
3.An Association Study of the Signal Transducer and Activator of Transcription 6 Gene With Periodic Psychosis.
Seiya KAWASHIGE ; Tetsufumi KANAZAWA ; Atsushi TSUTSUMI ; Hiroki KIKUYAMA ; Hiroyuki UENISHI ; Jun KOH ; Hiroshi YONEDA
Psychiatry Investigation 2008;5(1):41-44
OBJECTIVE: Recent molecular and genetic investigations have suggested that the current nosology for major psychiatric disorders, based on the "two-entities-principal" is not accurate with respect to clinical observations; patient groups that do not fit to the current operative diagnostic boundaries are readily identified. We aimed to perform an investigation of the signal transducer and activator of transcription 6 (STAT6) gene (located on 12q13), which has an important role in the apoptotic cascade, with patients suffering from periodic psychosis. METHODS: Genetic association study has been employed for the current work. Investigated six tag-SNPs were chosen from Hapmap database. RESULTS: Among six tag-SNPs, one marker (rs10783813), located in the STAT6 gene, showed modest association (p<0.05), although no marker or haplotype block showed association after Bonferroni's correction. CONCLUSION: Future studies will reveal the etiological role of STAT6, and of other genes of the apoptotic cascade, in major psychiatric disorders.
Genetic Association Studies
;
Haplotypes
;
HapMap Project
;
Humans
;
Psychotic Disorders*
;
STAT6 Transcription Factor*
4.Comparative Analysis of the WISC between Two ADHD Subgroups
Yoichiro KUBO ; Tetsufumi KANAZAWA ; Yasuo KAWABATA ; Koyuki TANAKA ; Tatsushi OKAYAMA ; Miho FUJTA ; Atsushi TSUTSUMI ; Shingo YOKOTA ; Hiroshi YONEDA
Psychiatry Investigation 2018;15(2):172-177
OBJECTIVE: The prevalence of attention deficit/hyperactivity disorder (ADHD) in school-age children is 7.2%, and ADHD is divided into clinical subtypes. METHODS: The current study explored whether specific cognitive profiles as assessed using the Wechsler Intelligence Scale for Children (WISC)-IV could be obtained for each clinical ADHD subtype (ADHD-Inattentive type and ADHD-Combined type) and investigated the correlation between WISC scores and parental age at their children’s birth or birthweight. The enrolled sample comprised 12 ADHD-I and 15 ADHD-C subjects. RESULTS: An impaired Processing Speed Index was found in ADHD-I. The age of the father at the child’s birth and birthweight positively correlated with the full scale intelligence quotient (FSIQ) score in the WISC assessment. CONCLUSION: Inattentiveness within the behaviors of the children with ADHD-I is partly due to the impaired processing speed, therefore effective support for ADHD will be conducted if educator decreases their speaking speed. Since biological basis of ADHD is still largely unknown, future studies using both psychological and biological methods will reveal the etiology of ADHD. These scientific assessments will provide information for more effective approaches in the care of children with ADHD.
Child
;
Cognitive Science
;
Fathers
;
Humans
;
Intelligence
;
Neurodevelopmental Disorders
;
Parents
;
Parturition
;
Prevalence
5.Increases in iPS Transcription Factor (Oct4, Sox2, c-Myc, and Klf4) Gene Expression after Modified Electroconvulsive Therapy.
Masaki NISHIGUCHI ; Hiroki KIKUYAMA ; Tetsufumi KANAZAWA ; Atsushi TSUTSUMI ; Takao KANEKO ; Hiroyuki UENISHI ; Yasuo KAWABATA ; Seiya KAWASHIGE ; Jun KOH ; Hiroshi YONEDA
Psychiatry Investigation 2015;12(4):532-537
OBJECTIVE: Electroconvulsive therapy (ECT) is a reasonable option for intractable depression or schizophrenia, but a mechanism of action has not been established. One credible hypothesis is related to neural plasticity. Three genes (Oct4, Sox2, c-Myc) involved in the induction of induced pluripotent stem (iPS) cells are Wnt-target genes, which constitute a key gene group involved in neural plasticity through the TCF family. Klf4 is the other gene among Yamanaka's four transcription factors, and increases in its expression are induced by stimulation of the canonical Wnt pathway. METHODS: We compared the peripheral blood gene expression of the four iPS genes (Oct4, Sox2, c-Myc, and Klf4) before and after modified ECT (specifically ECT with general anesthesia) of patients with intractable depression (n=6) or schizophrenia (n=6). Using Thymatron ten times the total bilateral electrical stimulation was evoked. RESULTS: Both assessments of the symptoms demonstrated significant improvement after mECT stimulation. Expression of all four genes was confirmed to increase after initial stimulation. The gene expression levels after treatment were significantly different from the initial gene expression in all twelve cases at the following treatment stages: at the 3rd mECT for Oct4; at the 6th and 10th mECT for Sox2; and at the 3rd, 6th and 10th mECT for c-Myc. CONCLUSION: These significant differences were not present after correction for multiple testing; however, our data have the potential to explain the molecular mechanisms of mECT from a unique perspective. Further studie should be conducted to clarify the pathophysiological involvement of iPS-inducing genes in ECT.
Depression
;
Electric Stimulation
;
Electroconvulsive Therapy*
;
Gene Expression*
;
Humans
;
Induced Pluripotent Stem Cells
;
Plastics
;
Schizophrenia
;
Transcription Factors*
;
Wnt Signaling Pathway
6.Genetic Polymorphisms in Dopamine- and Serotonin-Related Genes and Treatment Responses to Risperidone and Perospirone.
Atsushi TSUTSUMI ; Tetsufumi KANAZAWA ; Hiroki KIKUYAMA ; Gaku OKUGAWA ; Hiroyuki UENISHI ; Toshio MIYAMOTO ; Naoki MATSUMOTO ; Jun KOH ; Kazuhiro SHINOSAKI ; Toshifumi KISHIMOTO ; Hiroshi YONEDA ; Toshihiko KINOSHITA
Psychiatry Investigation 2009;6(3):222-225
We investigated the possible association between genetic polymorphisms in the dopamine receptor and serotonin transporter genes and the responses of schizophrenic patients treated with either risperidone or perospirone. The subjects comprised 27 patients with schizophrenia who were clinically evaluated both before and after treatment. The genotyping of the polymorphisms of the dopamine D2 receptor gene (DRD2) (rs1801028 and rs6277), the dopamine D4 receptor gene (DRD4) (120-bp tandem repeats and rs1800955), and serotonin transporter gene (5HTT)(variable number of tandem repeats; VNTR) were performed using the real-time polymerase chain reaction and sequencing. In DRD2 and 5HTT-VNTR, there were no significant correlations between clinical response and polymorphism in the case of risperidone, and for perospirone treatment it was impossible to analyze the clinical evaluation due to the absence of genotype information. On the other hand, in DRD4 there were significant correlations in the two-factor interaction effect on the Positive and Negative Syndrome Scale (PANSS) between the two drugs [120-bp tandem repeat, p=0.003; rs1800955, p=0.043]. Although the small sample represents a serious limitation, these results suggest that variants in DRD4 are a predictor of whether treatment will be more effective with risperidone or with perospirone in individual patients.
Genotype
;
Hand
;
Humans
;
Isoindoles
;
Polymorphism, Genetic
;
Real-Time Polymerase Chain Reaction
;
Receptors, Dopamine
;
Receptors, Dopamine D2
;
Receptors, Dopamine D4
;
Risperidone
;
Schizophrenia
;
Serotonin Plasma Membrane Transport Proteins
;
Tandem Repeat Sequences
;
Thiazoles
7.Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study
Michihiro IWAKI ; Hideki FUJII ; Hideki HAYASHI ; Hidenori TOYODA ; Satoshi OEDA ; Hideyuki HYOGO ; Miwa KAWANAKA ; Asahiro MORISHITA ; Kensuke MUNEKAGE ; Kazuhito KAWATA ; Tsubasa TSUTSUMI ; Koji SAWADA ; Tatsuji MAESHIRO ; Hiroshi TOBITA ; Yuichi YOSHIDA ; Masafumi NAITO ; Asuka ARAKI ; Shingo ARAKAKI ; Takumi KAWAGUCHI ; Hidenao NORITAKE ; Masafumi ONO ; Tsutomu MASAKI ; Satoshi YASUDA ; Eiichi TOMITA ; Masato YONEDA ; Akihiro TOKUSHIGE ; Yoshihiro KAMADA ; Hirokazu TAKAHASHI ; Shinichiro UEDA ; Shinichi AISHIMA ; Yoshio SUMIDA ; Atsushi NAKAJIMA ; Takeshi OKANOUE ;
Clinical and Molecular Hepatology 2024;30(2):225-234
Background/Aims:
Metabolic dysfunction-associated steatotic liver disease (MASLD) was recently proposed as an alternative disease concept to nonalcoholic fatty liver disease (NAFLD). We aimed to investigate the prognosis of patients with biopsy-confirmed MASLD using data from a multicenter study.
Methods:
This was a sub-analysis of the Clinical Outcome Nonalcoholic Fatty Liver Disease (CLIONE) study that included 1,398 patients with NAFLD. Liver biopsy specimens were pathologically diagnosed and histologically scored using the NASH Clinical Research Network system, the FLIP algorithm, and the SAF score. Patients who met at least one cardiometabolic criterion were diagnosed with MASLD.
Results:
Approximately 99% of cases (n=1,381) were classified as MASLD. Patients with no cardiometabolic risk (n=17) had a significantly lower BMI than patients with MASLD (20.9 kg/m2 vs. 28.0 kg/m2, P<0.001), in addition to significantly lower levels of inflammation, ballooning, NAFLD activity score, and fibrosis stage based on liver histology. These 17 patients had a median follow-up of 5.9 years, equivalent to 115 person-years, with no deaths, liver-related events, cardiovascular events, or extrahepatic cancers. The results showed that the prognosis for pure MASLD was similar to that for the original CLIONE cohort, with 47 deaths and one patient who underwent orthotopic liver transplantation. The leading cause of death was extrahepatic cancer (n=10), while the leading causes of liver-related death were liver failure (n=9), hepatocellular carcinoma (n=8), and cholangiocarcinoma (n=4).
Conclusions
Approximately 99% of NAFLD cases were considered MASLD based on the 2023 liver disease nomenclature. The NAFLD-only group, which is not encompassed by MASLD, had a relatively mild histopathologic severity and a favorable prognosis. Consequently, the prognosis of MASLD is similar to that previously reported for NAFLD.
8.Validity of Japanese Version of Neuropathic Pain Screening Questionnaire for Cancer Pain with Neuropathic Pain
Yumi IKEJIRI ; Kyoko OSHITA ; Ryuji NAKAMURA ; Hiroshi HAMADA ; Yumi HAYASHI ; Akiko KURATA ; Yasumasa OKAMOTO ; Masashi KAWAMOTO ; Yasuo TSUTSUMI
Palliative Care Research 2020;15(1):15-20
Introduction: The diagnosis of cancer-related neuropathic pain is often difficult for non-pain medicine specialists. We examined whether a Japanese version of a neuropathic pain screening questionnaire (Japan-Q), which was developed for chronic pain, is appropriate for screening cancer-related neuropathic pain. Methods: Our palliative care team screened 104 patients from May 2014 to December 2015 and compared total points of the Japan-Q with diagnosis of the type of cancer pain by specialized pain clinicians. Validity was evaluated using a receiver operating characteristic (ROC) curve. Results: The area under the ROC curve in terms of the total score, sensitivity, and specificity for the Japan Q was 0.82, which indicated a moderate level of diagnostic accuracy. A cut-off value of 3 points was shown to be best (sensitivity: 79%, specificity: 82%). When a cut-off value of 9 points was used as the diagnostic criterion for neuropathic pain, there was greatly reduced sensitivity (sensitivity: 40%, specificity: 97%). Conclusion: Although the Japan-Q shows moderate diagnostic accuracy related to cancer pain, the cut-off value for this tool is lower than that for chronic pain. Cancer-related neuropathic pain should be suspected with a total score of 3 or more in the Japan-Q.